Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Scheinberg

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Melanoma Research|December 1, 1992
Treatment with high dose mouse monoclonal (anti-GD3) antibody R24 in patients with metastatic melanomaD F Bajorin, P B Chapman, G Y Wong, et al.
Nature Medicine|January 14, 1998
Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progressionC N Papandreou, B Usmani, Y Geng, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Melanoma Research|December 1, 1992
Treatment with high dose mouse monoclonal (anti-GD3) antibody R24 in patients with metastatic melanomaD F Bajorin, P B Chapman, G Y Wong, et al.
Nature Medicine|January 14, 1998
Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progressionC N Papandreou, B Usmani, Y Geng, et al.
Pageof 2